medline.ch Respirationstrakt Neoplasie

	Emerging molecular probes for lung cancer: Targets, translational evidence, and theranostic potential. Lung Cancer Yu Z, Sun X, Wang P, Zheng M, Xing L, Sun X. PMID: 43033550 [PubMed - as supplied by publisher]
	Subclinical cardiac autonomic and pulmonary dysfunction in ambulatory patients with cervicothoracic intradural spinal tumours: A prospective cross-sectional study. J Clin Neurosci Parani L, Gopalakrishna KN, Prabhuraj AR, Pruthi N, Sathyaprabha TN, Udupa K. PMID: 43033486 [PubMed - as supplied by publisher]
	Comparative assessment of respiratory-induced tumor motion using fluoroscopy and four-dimensional CT of solitary pulmonary lesions. J Appl Clin Med Phys Kato M, Kato T, Narita Y, Murakami M. PMID: 43033405 [PubMed - indexed for MEDLINE]
	Cardiac substructure dose in thoracic VMAT without explicit constraints: FMO versus SPO on uRT-TPOIS with cross-platform reference to eclipse PO. J Appl Clin Med Phys Wu C, Cao Z, Duan T, Han L, Wang B, Lei W. PMID: 43033214 [PubMed - indexed for MEDLINE]
	Can the anesthetic management affect oncological outcome in lung cancer surgery? Curr Opin Anaesthesiol Kim J, Choi JW, Ahn HJ. PMID: 43033142 [PubMed - as supplied by publisher]
	Smart nanomedicine for lung cancer: Overcoming drug resistance and therapeutic barriers through targeted delivery, phototherapy, and theranostics. Int J Pharm X Colaco V, Gupta A, Jadhav SR, Rajora AD, Saha M, Adile S, Roy AA, Soman S, Moorkoth S, Datta D, Mutalik S, Prajapati BG, Kudarha R, Dhas N. PMID: 43032665 [PubMed]
	Immunomodulatory mechanisms of gut microbiota-derived metabolites in non-small cell lung cancer: a gut-lung axis perspective. Front Immunol Ye S, Tian T, Huangfu J, Liu H, Liu P, Zhou J. PMID: 43032549 [PubMed - indexed for MEDLINE]
	Clinical outcomes, anticoagulation practice patterns, and quality of life after cancer-associated pulmonary embolism: secondary outcomes of the Hydra randomized clinical trial. Res Pract Thromb Haemost Akerboom B, Martens ESL, Buechler B, Valerio L, Konstantinides S, Coppens M, Couturaud F, van Dooren YPA, Grootenboers MJJH, van der Griend R, Jiménez D, Leentjens J, Pola R, Talerico R, Tritschler T, Cate HT, Hamulýak K, van Mens TE, Klok FA, Huisman MV. PMID: 43032401 [PubMed - indexed for MEDLINE]
	Delaying thoracic radiotherapy does not compromise overall survival in extensive-stage small cell lung cancer after first-line systemic treatment: a multicenter real-world cohort study. Clin Transl Radiat Oncol Zheng L, Le X, Huang Y, Cheng Q, Ying Z, Ding Y, Ye R, Zhang F, Chen H, Wang E, Zhu L, Yan R, You G, Wang S, Sun X, Wang Y, Fang J, Xu Y, Zhou Z. PMID: 43032292 [PubMed]
	Risk prediction for locoregional recurrence in mutant-negative unresectable stage III non-small cell lung cancer after concurrent chemoradiotherapy: A retrospective study. Oncol Lett Liu J, Qiu Y, Yang Z, Sun Y. PMID: 43032124 [PubMed]
	Small Cell Lung Cancer Developing After Regression of Clinically Suspected Methotrexate-Associated Lymphoproliferative Disorder: A Diagnostic Pitfall in Rheumatoid Arthritis. Respirol Case Rep Nagayoshi T, Kai Y, Takano M, Suzuki K, Osa T, Harunari K, Iwasa Y, Fujioka N, Ota K, Kataoka R, Furutaka S, Furuyama T, Miyataka Y, Ibaraki T, Tanimura K, Yamamoto Y, Muro S. PMID: 43032111 [PubMed]
	Immune checkpoint inhibitor-based vs. non-immunotherapy subsequent treatment after progression on first-line chemoimmunotherapy in extensive-stage small cell lung cancer: A meta-analysis. Oncol Lett Long C, Ruan Y, Yang A, Xu S, Han J. PMID: 43031952 [PubMed]
	Risk prediction models for postoperative pneumonia in lung cancer patients: a systematic review and meta-analysis. Front Oncol Li C, Jiang Y, Wang Y. PMID: 43031605 [PubMed]
	MRI-Based Radiomics-Clinical Model for Predicting Overall Survival in Lung Cancer Patients: A Single-Center Study. Technol Cancer Res Treat Li J, Hu Y, Wang C, Liu H, Zhang Z, Hu S, Ma J, Liu S, Xu J, Yao L. PMID: 43031536 [PubMed - indexed for MEDLINE]
	Transcutaneous Electrical Acupoint Stimulation Combined with General Anesthesia in Minimally Invasive Surgery for Lung Cancer: A Randomized, Patient- and Assessor-Blinded, Sham-Controlled Trial. J Clin Med Zhang Y, Yan W, Wei J, Wang J, Wan Y, Liu F, Chen J. PMID: 43030768 [PubMed]
	A Preoperative Risk-Prediction Model (SSPAL) for Prolonged Air Leak After Lobectomy for Lung Cancer: Development and Internal Validation. J Clin Med Türk Y, Çitak N, Yamansavc, Üçvet A. PMID: 43030511 [PubMed]
	Exploratory Integrated Clinical Score and ICF-Defined Functioning in Non-Small Cell Lung Cancer: A Cross-Sectional Study. J Clin Med X Pencea X TG, B, Ro, Matei D, Tr. PMID: 43030355 [PubMed]
	Real-World Treatment Outcomes and Prognostic Factors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer: A Single-Center Study from a High-Volume Tertiary Chest Hospital. J Clin Med Koçano, Ünsal O, Ku, Gürçay N, Zeynelgil E, Düzköprü Y, Karakaya S. PMID: 43030350 [PubMed]
	Lung Cancer Mortality and In-Hospital Outcomes in Chile: A Population-Based Cross-Sectional Study. Healthcare (Basel) Delgado I, Bernal YA, Campaña C, Vial MR, Asenjo-Lobos C, González C, Olea A, Meza-Fuentes G, López R, Godoy-Faúndez A, Rivera D, Carrillo D. PMID: 43028709 [PubMed]
	Circulating MicroRNAs in Lung Cancer and Pulmonary Tuberculosis: Diagnostic Potential, Shared Signatures, and Challenges in Differential Diagnosis. Diagnostics (Basel) Khamitova N, Nurmukhanbetova A, Hamoudi R, Kamalieva M, Jainakbayev N, Baisynov N, Sharipov K. PMID: 43028489 [PubMed]

Artikel 1 - 20 / 164596

Seite 1 von 8230



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung